California-based obesity-focused clinical-stage pharma Aardvark Therapeutics saw its shares tumble nearly 26% to $4.99, after it announced that the US Food and Drug Administration (FDA) has placed a ...
Swedish neuroscience specialist BioArctic (Nasdaq Stockholm: BIOA B) said partner Eisai expects Alzheimer’s disease therapy ...
Fasenra (benralizumab) has received US Food and Drug Administration (FDA) approval for the treatment of patients 12 years and older with hypereosinophilic syndrome (HES) without an identifiable ...
US biotech Regenxbio (Nasdaq: RGNX) announced top-line and interim functional data from the pivotal Phase III portion of the Phase I/II/III AFFINITY DUCHENNE trial of RGX-202, a potential ...
39-43 Putney High Street, Putney London, SW15 1SP United Kingdom ...
A China-based biotechnology company focused on developing innovative oncology and immuno-oncology therapies with multiple approved drugs and a robust pipeline targeting various cancer types. A ...
A clinical-stage oncology company headquartered in Cambridge, Massachusetts. The company operates as a U.S.-based R&D organization progressing peptide therapeutics into global clinical development ...
A clinical-stage biotechnology company based in the Boston, Massachusetts area. The company is developing targeted radiopharmaceuticals for solid tumors and runs clinical development through ...
Vetter is celebrating the start of construction on its new site in Saarlouis with a traditional ground-breaking ceremony today.
Bristol Myers Squibb’s Eliquis (apixaban) is on course for one of the largest single-asset revenue collapses in ...
US regulator the Food and Drug Administration has granted accelerated approval to Beqalzi (sonrotoclax), giving BeOne ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results